Damn wish I had puts on this!-To The Moon - Tiger Brokers Online Investing Community - To The Moon

1
2
Favorite

kingcrayon
2021-09-03

Damn wish I had puts on this!

Forte Biosciences' shares fall 82% after scrapping development of FB-401 treatment

Forte Biosciences announces that it will not continue to advance the development of its atopic derma

Forte Biosciences' shares fall 82% after scrapping development of FB-401 treatment

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

1

Report

Comment（2）

Top
Latest

Mattsailor
·2021-09-03
No you don't. Problem is the put option strike price available doesn't go 80% below the stock price before the fall. I got slightly burned. [嘘]
Reply
Like
Report
Fold Replies
- Mattsailor:
  Apologies, you are right. You would have made some money if you had bought any puts.
  2021-09-05
  Reply
  Report

Most Discussed

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"data":{"magic":2,"id":812754922,"tweetId":"812754922","gmtCreate":1630626922066,"gmtModify":1676530358298,"author":{"id":3577554594597387,"idStr":"3577554594597387","authorId":3577554594597387,"authorIdStr":"3577554594597387","name":"kingcrayon","avatar":"https://static.tigerbbs.com/0c00dd711d203002c2d9e78a4f2445cb","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":0,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>Damn wish I had puts on this!&nbsp;</p></body></html>","htmlText":"<html><head></head><body><p>Damn wish I had puts on this!&nbsp;</p></body></html>","text":"Damn wish I had puts on this!","highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":2,"repostSize":0,"favoriteSize":0,"link":"https://ttm.financial/post/812754922","repostId":1186835624,"repostType":2,"repost":{"id":"1186835624","pubTimestamp":1630625981,"share":"https://www.laohu8.com/m/news/1186835624?lang=&edition=full","pubTime":"2021-09-03 07:39","market":"us","language":"en","title":"Forte Biosciences' shares fall 82% after scrapping development of FB-401 treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=1186835624","media":"seekingalpha","summary":"Forte Biosciences announces that it will not continue to advance the development of its atopic derma","content":"<p>Forte Biosciences&nbsp;announces that it&nbsp;will not continue to advance the development of its atopic dermatitis treatment FB-401 following mid-stage trial results.</p>\n<p>Shares slide nearly&nbsp;82%&nbsp;post market.</p>\n<p><img src=\"https://static.tigerbbs.com/ba305cccf4317784780adcba0d37993e\" tg-width=\"1020\" tg-height=\"522\" width=\"100%\" height=\"auto\"></p>\n<p>In the phase 2 study, the drug failed to meet statistical significance for the primary endpoint of EASI-50 (the proportion of patients with at least a 50% improvement in atopic dermatitis disease severity as measure by EASI), the company said.</p>\n<p>\"The topline data is disappointing and we will continue to analyze the data; however, given this readout we will not continue to advance FB-401,\" CEO Paul Wagner said.</p>\n<p>Forte Biosciences previously reported that it had cash and cash equivalents of $50.8M as of June 30, 2021.</p>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Forte Biosciences' shares fall 82% after scrapping development of FB-401 treatment</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nForte Biosciences' shares fall 82% after scrapping development of FB-401 treatment\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-03 07:39 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3736993-forte-biosciences-shares-fall-12-after-scrapping-development-of-fb-401-treatment><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Forte Biosciences announces that it will not continue to advance the development of its atopic dermatitis treatment FB-401 following mid-stage trial results.\nShares slide nearly 82% post market.\n\nIn ...</p>\n\n<a href=\"https://seekingalpha.com/news/3736993-forte-biosciences-shares-fall-12-after-scrapping-development-of-fb-401-treatment\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"FBRX":"Forte BioSciences Inc"},"source_url":"https://seekingalpha.com/news/3736993-forte-biosciences-shares-fall-12-after-scrapping-development-of-fb-401-treatment","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"1186835624","content_text":"Forte Biosciences announces that it will not continue to advance the development of its atopic dermatitis treatment FB-401 following mid-stage trial results.\nShares slide nearly 82% post market.\n\nIn the phase 2 study, the drug failed to meet statistical significance for the primary endpoint of EASI-50 (the proportion of patients with at least a 50% improvement in atopic dermatitis disease severity as measure by EASI), the company said.\n\"The topline data is disappointing and we will continue to analyze the data; however, given this readout we will not continue to advance FB-401,\" CEO Paul Wagner said.\nForte Biosciences previously reported that it had cash and cash equivalents of $50.8M as of June 30, 2021.","news_type":1},"isVote":1,"tweetType":1,"viewCount":239,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":23,"xxTargetLangEnum":"ORIG"},"commentList":[{"id":5738353,"commentId":"5738353","gmtCreate":1630638547954,"gmtModify":1663233321735,"authorId":3585191808723701,"author":{"id":3585191808723701,"idStr":"3585191808723701","authorId":3585191808723701,"name":"Mattsailor","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":8,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":812754922,"objectIdStr":"812754922","type":1,"supId":0,"supIdStr":"0","prevId":0,"prevIdStr":"0","content":"No you don't. Problem is the put option strike price available doesn't go 80% below the stock price before the fall. I got slightly burned.  [嘘]","text":"No you don't. Problem is the put option strike price available doesn't go 80% below the stock price before the fall. I got slightly burned.  [嘘]","html":"No you don't. Problem is the put option strike price available doesn't go 80% below the stock price before the fall. I got slightly burned.  [嘘]","likeSize":0,"commentSize":1,"subComments":[{"id":5757772,"commentId":"5757772","gmtCreate":1630811198066,"gmtModify":1663233408545,"authorId":3585191808723701,"author":{"id":3585191808723701,"idStr":"3585191808723701","authorId":3585191808723701,"name":"Mattsailor","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":8,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":812754922,"objectIdStr":"812754922","type":1,"supId":5738353,"supIdStr":"5738353","prevId":0,"prevIdStr":"0","content":"Apologies, you are right. You would have made some money if you had bought any puts.","text":"Apologies, you are right. You would have made some money if you had bought any puts.","html":"Apologies, you are right. You would have made some money if you had bought any puts."}],"verified":10,"allocateAmount":0,"commentType":"valid","coins":0,"score":0}],"hasMoreComment":true,"orderType":2}